October 17, 2011

Children can be diagnosed with attention deficit hyperactivity disorder as soon as 4 years old, according to new guidelines released Sunday by the American Academy of Pediatrics.

October 17, 2011

Generic drug maker Watson Pharmaceuticals is seeking Food and Drug Administration approval for a generic treatment for attention deficit hyperactivity disorder, the company said.

July 8, 2011

Watson Pharmaceuticals has filed with the Food and Drug Administration for regulatory approval for a drug to treat attention deficit hyperactivity disorder, the company said Thursday.

July 5, 2011

Shire has filed patent infringement suits against two generic drug makers relating to its attention deficit hyperactivity disorder treatment.

May 20, 2011

Sandoz is looking to market a generic version of a Shire drug for treating attention deficit hyperactivity disorder.

May 9, 2011

Alza Corp. is attempting to block Impax Labs from developing a generic version of Alza's attention deficit hyperactivity disorder treatment.

May 2, 2011

Watson Pharmaceuticals has launched an authorized generic version of a Johnson & Johnson drug for treating attention deficit hyperactivity disorder through a subsidiary, Watson said Monday.

April 6, 2011

British drug maker Shire has filed suit against Watson Pharmaceuticals and subsidiaries, alleging patent infringement in a case concerning a drug used to treat attention deficit hyperactivity disorder.

February 28, 2011

The Food and Drug Administration has approved a new use for a Shire drug to treat attention deficit hyperactivity disorder, Shire said Monday.

February 25, 2011

Watson Labs is hoping to be the first to market a generic version of a popular drug for attention deficit hyperactivity disorder.

January 10, 2011

Drug maker Shionogi has launched a new medication for attention deficit hyperactivity disorder, the company said Monday.

December 28, 2010

Health professionals worry that little is known about the long-term effects of many drugs — which have been tested extensively on adult-patient populations — on children.

November 14, 2010

The Food and Drug Administration has approved an attention deficit hyperactivity disorder drug for use...

October 27, 2010

Sexual dysfunction often is conceived as a male phenomenon, but it frequently affects women as...

October 3, 2010

The Food and Drug Administration has approved a nonstimulant drug for treating attention deficit hyperactivity...

August 31, 2010

A generic drug maker has received regulatory approval for its version of an attention deficit...

August 10, 2010

The Food and Drug Administration has approved a late-stage clinical trial of a drug for...

July 19, 2010

More than 300 medications for treating mental disorders are in development, according to a new...

July 6, 2010

The Food and Drug Administration has approved a drug made by Shire for treating attention...

May 20, 2010

British drug maker Shire presented late-stage clinical study data at a psychiatric meeting Friday indicating...

May 19, 2010

British drug maker Shire will present data on two attention deficit hyperactivity disorder treatments in...

March 3, 2010

The U.S. District Court for the District of Columbia has upheld a decision by the...